Literature DB >> 24083568

Gold(I)-catalyzed asymmetric induction of planar chirality by intramolecular nucleophilic addition to chromium-complexed alkynylarenes: asymmetric synthesis of planar chiral (1H-isochromene and 1,2-dihydroisoquinoline)chromium complexes.

Masato Murai1, Yumi Sota, Yuki Onohara, Jun'ichi Uenishi, Motokazu Uemura.   

Abstract

Gold(I)-catalyzed asymmetric intramolecular cyclization of prochiral 1,3-dihydroxymethyl-2-alkynylbenzene or 1,3-bis(carbamate)-2-alkynylbenzene tricarbonylchromium complexes with axially chiral diphosphine ligand gave planar chiral tricarbonylchromium complexes of 1H-isochromene or 1,2-dihydroisoquinoline with high enantioselectivity. An enantiomeric excess of the planar chiral arene chromium complexes was largely affected by a combination of axially chiral diphosphine(AuCl)2 precatalysts and silver salts. In the case of 1,3-dihydroxymethyl-2-alkynylbenzene chromium complexes, a system of segphos(AuCl)2 with AgBF4 resulted in the formation of the corresponding antipode.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24083568     DOI: 10.1021/jo401893f

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Gold(I)-Catalyzed Desymmetrization of 1,4-Dienes by an Enantioselective Tandem Alkoxylation/Claisen Rearrangement.

Authors:  Hongmiao Wu; Weiwei Zi; Guigen Li; Hongjian Lu; F Dean Toste
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-01       Impact factor: 15.336

2.  Synthesis of isochromene-type scaffolds via single-flask Diels-Alder-[4 + 2]-annulation sequence of a silyl-substituted diene with menadione.

Authors:  Jihoon Lee; James S Panek
Journal:  Org Lett       Date:  2014-06-11       Impact factor: 6.005

3.  Catalytic Asymmetric C-H Arylation of (η6-Arene)Chromium Complexes: Facile Access to Planar-Chiral Phosphines.

Authors:  María Batuecas; Junfei Luo; Ivana Gergelitsová; Katrina Krämer; Daniel Whitaker; Iñigo J Vitorica-Yrezabal; Igor Larrosa
Journal:  ACS Catal       Date:  2019-04-25       Impact factor: 13.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.